nafamostat

inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Also Known As:

6'-amidino-2-naphthyl 4-guanidinobenzoate; 6'-amidino-2-naphthyl 4-guanidinobenzoate, dimethanesulfonate; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dihydrochloride; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dimethanesulfonate; CKD-314; CKD314; FUT 175; FUT-175; Ronastat; nafamostat dihydrochloride; nafamostat mesilate; nafamostat mesylate; nafamstat mesilate

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal
D000925 - Anticoagulants
D011480 - Protease Inhibitors
D014361 - Trypsin Inhibitors
D015842 - Serine Proteinase Inhibitors
D051056 - Complement Inactivating Agents

Organic Chemicals: 140
- Amidines: 15
  - Guanidines: 29
    - nafamostat: 426
  - Benzamidines: 5
    - nafamostat: 426

Ayako Ohkawara Selected Research

Ayako Ohkawara Research Topics

Disease

Drug/Important Bio-Agent (IBA)